Article Versions Notes

Wakisaka R, Yamaki H, Kono M, Inoue T, Sato R, Komatsuda H, Ohara K, Kosaka A, Ohkuri T, Nagato T, et al. Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer. Cancers. 2024; 16(17):3013. https://doi.org/10.3390/cancers16173013

Wakisaka, Risa, Hidekiyo Yamaki, Michihisa Kono, Takahiro Inoue, Ryosuke Sato, Hiroki Komatsuda, Kenzo Ohara, Akemi Kosaka, Takayuki Ohkuri, Toshihiro Nagato, and et al. 2024. "Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer" Cancers 16, no. 17: 3013. https://doi.org/10.3390/cancers16173013

Wakisaka, R., Yamaki, H., Kono, M., Inoue, T., Sato, R., Komatsuda, H., Ohara, K., Kosaka, A., Ohkuri, T., Nagato, T., Kishibe, K., Nakayama, K., Kobayashi, H., Kumai, T., & Takahara, M. (2024). Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer. Cancers, 16(17), 3013. https://doi.org/10.3390/cancers16173013